✦ LIBER ✦

The Role of Thrombin Inhibition During Percutaneous Coronary Intervention

✍ Scribed by Ann K. Wittkowsky

Book ID: 115048403
Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 109 KB
Volume: 22
Category: Article
ISSN: 0277-0008
DOI: 10.1592/phco.22.10.97s.33614

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The role of distal myocardial protection

The role of distal myocardial protection devices during percutaneous coronary interventions

✍ Diana A. Gorog 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 119 KB

Effects of platelet glycoprotein IIb/III

Effects of platelet glycoprotein IIb/IIIa inhibition with abciximab on thrombin generation and activity during percutaneous coronary intervention

✍ George Dangas; Jonathan D. Marmur; Traci E. King; Joshua De Leon; Samin K. Sharm 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 170 KB

The caregiving role following percutaneo

The caregiving role following percutaneous coronary intervention

✍ John Rolley; Janice Smith; Michelle DiGiacomo; Yenna Salamonson; Patricia Davids 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB

Thrombus aspiration during percutaneous

Thrombus aspiration during percutaneous coronary intervention

✍ L Bonello; A De Labriolle; D Steinberg; R Waksman 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 40 KB

Thrombus aspiration during percutaneous

Thrombus aspiration during percutaneous coronary intervention

✍ Jaewon Oh; Namki Hong; Seok-Min Kang 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 40 KB

Platelet inhibition with tirofiban early

Platelet inhibition with tirofiban early during percutaneous coronary intervention: Dosing revisited

✍ Nasser Lakkis; Nada Lakiss; Jeremy Bobek; John Farmer 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

## Abstract Platelet inhibition is central to the efficacy of the intravenous glycoprotein IIb/IIIa receptor inhibitors. Differences in the degree of platelet inhibition achieved with these agents may account for the disparity in clinical efficacy noted in recently completed clinical trials. The pu